2013
DOI: 10.1016/j.chembiol.2013.09.018
|View full text |Cite
|
Sign up to set email alerts
|

Tracking Brain Palmitoylation Change: Predominance of Glial Change in a Mouse Model of Huntington’s Disease

Abstract: SUMMARY Protein palmitoylation, a reversible lipid modification of proteins, is widely used in the nervous system, with dysregulated palmitoylation being implicated in a variety of neurological disorders. Described below is ABE/SILAM, a new proteomic strategy that couples acyl-biotinyl exchange (ABE) purification of palmitoyl-proteins to whole animal stable isotope labeling (SILAM) to provide an accurate tracking of palmitoylation change within rodent disease models. As a first application, we have used ABE/SI… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
75
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 77 publications
(77 citation statements)
references
References 98 publications
2
75
0
Order By: Relevance
“…Furthermore, expression of mHTT in microglia is sufficient to produce an increase in pro-inflammatory gene expression and neurotoxic effect, making microglia to proliferate and turn in activated state, being closely linked the severity of the disease with the increase of microglia cell number. Inflammation is considered to appear early in the HD development and microglia responds to insults in the brain producing excess of inflammatory factors (Crotti et al, 2014;Kraft and Harry, 2011;Kraft et al, 2012;Tai et al, 2007;Wan et al, 2013). Our results showed an increase in microglia activation in HD vs WT, even further with epoxomicin treatment, but interestingly, trehalose balances the activated microglia profile.…”
Section: Glial Characterizationsupporting
confidence: 33%
See 3 more Smart Citations
“…Furthermore, expression of mHTT in microglia is sufficient to produce an increase in pro-inflammatory gene expression and neurotoxic effect, making microglia to proliferate and turn in activated state, being closely linked the severity of the disease with the increase of microglia cell number. Inflammation is considered to appear early in the HD development and microglia responds to insults in the brain producing excess of inflammatory factors (Crotti et al, 2014;Kraft and Harry, 2011;Kraft et al, 2012;Tai et al, 2007;Wan et al, 2013). Our results showed an increase in microglia activation in HD vs WT, even further with epoxomicin treatment, but interestingly, trehalose balances the activated microglia profile.…”
Section: Glial Characterizationsupporting
confidence: 33%
“…Microglia proliferation and its activated state are closely linked to the severity of the disease. Inflammation is considered to appear early in the HD development and microglia responds to insults in the brain producing excess of inflammatory factors (Crotti et al, 2014;Kraft and Harry, 2011;Kraft et al, 2012;Tai et al, 2007;Wan et al, 2013). Our results showed an early response of microglia in HD cultures, including elevated numbers and activated morphological amoeboid phenotype, even more with epoxomicin treatment, but interestingly, trehalose equilibrates the activated microglia profile.…”
Section: Glial Characterizationmentioning
confidence: 41%
See 2 more Smart Citations
“…Specifically, free cysteines in a cell lysate are alkylated with N -ethylmaleimide, followed by treatment with hydroxylamine, which acts to cleave any palmitate thioesters revealing sulfhydryl groups that are then selectively modified with biotinylation reagents. Importantly, this method was used for the identification of palmitoylated proteins in yeast (Roth et al, 2006), mammalian cells (Ivaldi et al, 2012), malaria parasites (Jones et al, 2012), and mouse tissue (Wan et al, 2013). S-prenylation has also been investigated using alkyne derivatives of isoprenoids (Charron et al, 2011; DeGraw et al, 2010).…”
Section: Lipidationmentioning
confidence: 99%